Results 21 to 30 of about 929,917 (139)
British Journal of Clinical Pharmacology, Volume 87, Issue 5, Page 2256-2273, May 2021., 2021 Aims Hypophosphataemia is an increasingly recognized side‐effect of ferric carboxymaltose (FCM) and possibly iron isomaltoside/ferric derisomaltose (IIM), which are used to treat iron deficiency. The aim of this study was to determine frequency, severity, duration and risk factors of incident hypophosphataemia after treatment with FCM and IIM.
Benedikt Schaefer +6 more
wiley +1 more source
Melt densities in the CaO-FeO-Fe2O3-SiO2 system and the compositional dependence of the partial molar volume of ferric iron in silicate melts [PDF]
, 1988 The densities of 10 melts in the CaO-FeO-Fe2O3-SiO2 system were determined in equilibrium with air, in the temperature range of 1200 to 1550°C, using the double-bob Archimedean technique.
Brearley, Mark, Dingwell, Donald B.
core +1 more source
Cancer Science, Volume 111, Issue 6, Page 2016-2027, June 2020., 2020 Malignant mesothelioma (MM) is one of the most lethal tumors. Its independent prognostic factors include younger age, female sex, epithelioid subtype and low clinical stage. Hierarchical clustering of miR expression profiles was impacted by the histological subtypes in rat MM.
Yasumasa Okazaki +8 more
wiley +1 more source
Recurrent severe hypophosphatemia following intravenous iron administration
Clinical Case Reports, Volume 8, Issue 2, Page 243-246, February 2020., 2020 Hypophosphatemia postintravenous iron is frequent but under‐recognized. If prolonged or recurrent, it can cause osteomalacia. The likely mechanisms are direct toxicity to proximal tubular cells causing phosphate wasting, elevated Fibroblast growth factor‐23 (FGF‐23), and reduced 1,25‐dihydroxyvitamin D (1,25(OH)2D).
Melissa Stephanie Nataatmadja +1 more
wiley +1 more source
PLoS ONE, 2014 BackgroundOxidative stress and smoking contribute to endothelial dysfunction. Iron might also play a role in oxidative stress generation and endothelial dysfunction.
Kei Fukami +4 more
doaj +1 more source
International Journal of Nephrology, Volume 2020, Issue 1, 2020., 2020 Optimal ferritin level in hemodialysis patients between Japan and other countries is controversial. Long‐term side effects of iron supplementation in these patients remain unclear. We aimed to elucidate whether past hyperferritinemia in hemodialysis patients was associated with high risk of death and cerebrovascular and cardiovascular diseases (CCVDs).
Sayako Maeda +6 more
wiley +1 more source
Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease [PDF]
, 2011 Background and Aims:We analyzed iron deficiency and the therapeutic response following intravenous ferric carboxymaltose in a large single-center inflammatory bowel disease (IBD) cohort.
Brand, Stephan +21 more
core +1 more source
Kidney & Blood Pressure Research, 2018 Background/Aims: Both iron deficiency and chronic inflammation are highly prevalent in patients with chronic kidney disease (CKD). The effect of intravenous iron infusion on mineral metabolism in CKD may be modified by inflammation.
Katarzyna Muras-Szwedziak +1 more
doaj +1 more source
Three cases of osteomalacia caused by intravenous administration of saccharated ferric oxide.
Orthopedics & Traumatology, 1990 Three cases of osteomalacia caused by intravenous administration of saccharated ferric oxide were reported. Three cases were female with ages of 51, 55 and 61 years old. They received saccharated ferric oxide intravenouslly for anemia, just before having back pain, low back pain and hip joint pain due to osteomalacia.
Kuranobu, Koji +3 more
openaire +2 more sources
The Ferric-superoxo Intermediate of the TxtE Nitration Pathway Resists Reduction, Facilitating Its Reaction with Nitric Oxide [PDF]
, 2021 TxtE is a cytochrome P450 (CYP) homolog that mediates the nitric oxide (NO)-dependent direct nitration of L-tryptophan (Trp) to form 4-nitro-L-tryptophan (4-NO2-Trp).
Jonathan, Caranto +5 more
core +2 more sources